eqvp glp-1 Nexa Med Spa GLP1-S (Starting at $25) -

For individuals with obesity however, exercise capacity can be limited by comorbidites associated with excess weight

Clinical Evidence: GLP-1 Treatment for NAFLD in the UK Emerging clinical evidence suggests GLP-1 receptor agonists may offer therapeutic benefits for patients with NAFLD and NASH, though it is important to note that these medications are not currently licensed specifically for liver disease treatment in the UK

And they should engage in regular physical activity, including strength training to help retain lean body mass

Accessed: 2024-12-07

It is therefore vital that the individual with obesity has in place a comprehensive support team providing mental/emotional as well as physical treatment strategies